Speaker(s): 

Dr. Gustaaf De Ridder, MD, PhD, Staff Member - has disclosures with Sanofi and Therakos.

Moderator(s): 

Dr. Keith Williams, MD, Staff member, Geisinger - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Define Thrombotic Microangiopathy (TMA) and the types of TMAs that affect pregnant women.
• Evaluate and compare the clinical and pathological features of disparate TMAs and explain how they can lead to a common outcome, Disseminated Intravascular Coagulation (DIC).
• Discuss management options for pregnant women with DIC.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Jay Bringman, MD, Sandra Culbertson, MD, Brittany Meyer, PA-C, Michelle Bafile, PA-C, Lindsay Payne, Stephanie Worhach, RN, Keith Williams, MD, and Orlando Valle, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose: Robert Cooney, MD, MSMedEd, FACEP, Gale Shalongo, DNP, MSN, RN, ACNS, BC

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None